Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction (Q36040691)

11 August 2017

1 reference

title

Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction (English)

1 reference

11 August 2017

Sheila A Doggrell

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

6

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

75-84

1 reference

Erectile dysfunction in general medicine practice: prevalence and clinical correlates

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Effects of SSRIs on sexual function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Effect of life-style factors on incidence of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Quality of partnership in patients with erectile dysfunction after sildenafil treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Switching from long-term treatment with self-injections to oral sildenafil in diabetic patients with severe erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Sildenafil use in patients with olanzapine-induced erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Early experience with sildenafil for the treatment of erectile dysfunction in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Effects of tadalafil on erectile dysfunction in men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Observational multicentric trial performed with doxazosin: evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.75

21 January 2018

Identifiers

DOI

10.1517/14656566.6.1.75

1 reference

11 August 2017

1 reference